Remap Consulting NICE presentation to EUCOPE

NICE’s highly specialized technology methodology to EUCOPE


Remap Consulting presented NICE’s methodology for highly specialized technologies (ultra orphan disease with a prevalence of <1:50,000) to EUCOPE members at their meeting in Brussels on the 20th November.

NICE Highly Specialised Technologies Process 1_0

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.